Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from ...
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...
The more complex and labor-intensive esoteric tests are reimbursed at a higher rate and often outsourced by hospitals to independent labs. Labcorp is funneling resources to broaden its menu of complex ...
Following a recall of grounding pads produced by Megadyne, a machinery industry company, the FDA is notifying veterinarians ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
LOS ANGELES, CA / ACCESS Newswire / February 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...
3dOpinion
Vaping has become more prevalent among young people in the 21st century. As companies continue appealing their products to ...
The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback